In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer discounted Humira alternative.
Mark Cuban calls Yusimry’s availability on MCCPDC ‘a game changer’
In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer discounted Humira alternative.
